Enalare Therapeutics, Inc.
🇺🇸United States
ENA-001 for Opioid Induced Respiratory Depression
Phase 1
Not yet recruiting
- Conditions
- Respiratory Depression
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Enalare Therapeutics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT06967259
ENA-001 for Post Operative Respiratory Depression (PORD)
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Enalare Therapeutics Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06137638
© Copyright 2025. All Rights Reserved by MedPath